📰 Murrays Kessler News
Page 2 - Murrays Kessler News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Murrays Kessler. Real-time updates on events, politics, business and more.
June 8, 2023
Gabelli Funds LLC boosted its stake in Perrigo Company plc (NYSE:PRGO – Get Rating) by 41.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 502,900 shares of the company’s stock after acquiring an additional 147,400 shares during the period. Gabelli Funds […]
June 1, 2023
Avalon Investment & Advisory cut its holdings in Perrigo Company plc (NYSE:PRGO – Get Rating) by 4.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 107,158 shares of the company’s stock after selling 4,901 shares during the quarter. Avalon Investment & Advisory […]
May 31, 2023
Pitcairn Co. lowered its stake in shares of Perrigo Company plc (NYSE:PRGO – Get Rating) by 9.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 25,525 shares of the company’s stock after selling 2,691 shares during the period. Pitcairn Co.’s holdings in Perrigo were worth $870,000 […]
May 26, 2023
Bryn Mawr Capital Management LLC grew its stake in Perrigo Company plc (NYSE:PRGO – Get Rating) by 190.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 29,605 shares of the company’s stock after buying an additional 19,423 shares during the period. Bryn Mawr […]
May 16, 2023
Swiss National Bank raised its holdings in shares of Perrigo Company plc (NYSE:PRGO – Get Rating) by 1.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 325,000 shares of the company’s stock after purchasing an additional 5,900 shares during […]
May 11, 2023
A panel of federal advisers voted in favor of a pharma company's request to sell a type of their birth control pills over the counter without a prescription.
May 10, 2023
The advisors vote is not binding, and the FDA is expected to make a final decision this summer.
May 10, 2023
The advisors vote is not binding, and the FDA is expected to make a final decision this summer.
May 10, 2023
The advisors vote is not binding, and the FDA is expected to make a final decision this summer.
May 10, 2023
The advisors vote is not binding, and the FDA is expected to make a final decision this summer.